Pharma ’ s broken business model — Part 2: Scraping the barrel in drug discovery
制药业破产的商业模式-第二部分 : 药物发现领域的竭泽而渔
by kelvin stott — on May 2, 2018 01:13 PM EDT
( 作者Kelvin Stott , 系诺华制药公司的研发组合投资管理经理 )
In Part 1 of this blog, I introduced a simple robust method to calculate Pharma ’ s Internal Rate of Return (IRR) in R&D, based only on the industry ’ s actual historic P&L performance. Further, I showed that P...
.